TSE:TST Telesta Therapeutics (TST) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free TST Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume292,300 shsAverage Volume212,584 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Telesta Therapeutics alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Telesta TherapeuticsTelesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. TST Stock News HeadlinesMarch 31, 2023 | markets.businessinsider.comTranscenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic CancerMarch 16, 2023 | msn.comSeelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of TodayApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. December 19, 2022 | msn.comMinnesota launches telehealth program to offer no-cost COVID-19 therapeuticsSeptember 15, 2022 | finance.yahoo.comTelo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical StudyAugust 16, 2022 | finance.yahoo.comDr. B Raises $8 Million for New Telehealth Service Making Prescription Medications Affordable & Accessible for AnyoneJuly 14, 2022 | finance.yahoo.comTrelica Named 'Leader' and 'Outperformer' in GigaOm's SaaS Management Platforms Radar ReportJune 13, 2022 | finance.yahoo.comTessa Therapeutics to Host Scientific Session on CD30 CAR-T targeting of CD30+ Lymphomas at the SDCT-REMEDIS Cell Therapy Conference 2022April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. June 8, 2022 | yahoo.comAUTEM THERAPEUTICS RAISES $10 MILLION SERIES A-1 FINANCING FOR NOVEL BIOELECTRIC CANCER TREATMENT PLATFORMAugust 29, 2021 | msn.comPod-TST: Instant Reaction to Rams falling to Broncos in preseason gameAugust 25, 2021 | news.yahoo.comGenius Pregnant Halloween Costumes for Mummies to BeAugust 24, 2021 | prnewswire.comWorldwide Tuberculosis Diagnostics Industry to 2026 - Featuring Abbott Laboratories, Alere and Cepheid Among OthersAugust 24, 2021 | finance.yahoo.comInsights on the Tuberculosis Diagnostics Global Market to 2026 - by Disease Stage, Test Type, End-user and RegionAugust 22, 2021 | msn.comPod-TST: Instant reaction to Rams 17-16 preseason loss to RaidersAugust 20, 2021 | markets.businessinsider.comMercantile Inv Tst : Ten Largest InvestmentsAugust 20, 2021 | msn.comPod-TST: Final Rams 2021 training camp observationsAugust 19, 2021 | msn.comHong Kong protests: opposition activists plead guilty to incitement over unauthorised march, which they claim more than 350,000 people attendedAugust 18, 2021 | finance.yahoo.comReusable Face Masks HK – Washable Cotton Masks For Kids Adults Hong Kong LaunchAugust 17, 2021 | msn.comHong Kong doctoral student arrested for animal cruelty after allegedly caught sprinkling salt over snailsAugust 16, 2021 | msn.comHong Kong doctoral student accused of covering snails in salt arrested on suspicion of animal crueltyAugust 15, 2021 | msn.comRams-Chargers instant reaction podcastAugust 14, 2021 | msn.comManulife plans office space, agency force expansion to capture growing insurance demand in Greater Bay AreaAugust 12, 2021 | markets.businessinsider.comSchroder Br.Opps.Tst : Director/PDMR ShareholdingSee More Headlines Receive TST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Telesta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolTSE:TST CUSIPN/A CIKN/A Webwww.telestatherapeutics.com Phone+1-514-5876148FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key Competitors(EDW.V)CVE:EDW(FSN.V)CVE:FSN(FTE.V)CVE:FTE108946 (AUA.V)CVE:AUA111040 (DNI.V)CVE:DNIView All Competitors TST Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Telesta Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Telesta Therapeutics investors own include Bombardier, Inc. Class B (BBD.B), Big Banc Split (BNK), Juno Therapeutics (JUNO), KalVista Pharmaceuticals (KALV), ProMetic Life Sciences (PLI), Petrowest (PRW), Sequans Communications (SQNS), BioLineRx (BLRX) and Bausch Health Companies (BHC). How do I buy shares of Telesta Therapeutics? Shares of TST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:TST) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesta Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
